HomeMedTechBeating the Odds:  Restore Medical's Mission to Change Heart Failure Forever

Beating the Odds:  Restore Medical’s Mission to Change Heart Failure Forever

When traditional heart treatments fall short, it’s not just the body that suffers—it’s hope that fades. But one Israeli med-tech startup is working to change that with a device small in size but massive in impact.

Restore Medical has a bold belief: “life with heart failure doesn’t have to mean decline, fear, or limits”. Their team has developed a minimally invasive implant designed to restore the heart’s shape and improve blood flow—without the trauma of open-heart surgery. This innovation steps in early, before patients are pushed to the edge, offering a chance to breathe easier, move freely, and live fully.

Co-Founded by Stephen Bellomo (CTO), Dr. Elchanan Bruckheimer (Medical Director), and Aaron Feldman and led by CEO Gilad Marom, Restore Medical is rewriting the script on how heart failure is managed—replacing long waits and risky interventions with precision, compassion, and hope.

This isn’t just a medical breakthrough. It’s a second chance—for millions.

Read also – The Story of Stoyana Natseva and Happy Life Academy Transforming Lives.

Reimagining Heart Failure Therapy

Heart failure affects over 64 million people globally, and despite years of pharmaceutical advances, many patients still suffer. Especially in cases of Heart Failure with reduced Ejection Fraction (HFrEF), symptoms persist even after standard treatments.

That’s where Restore Medical steps in—with a groundbreaking transcatheter implant engineered to improve the shape of the heart and restore healthy blood flow, without the need for risky and invasive open-heart surgery.

This innovative approach is about timing, dignity, and giving people their lives back. By stepping in earlier, before the condition becomes overwhelming, Restore Medical offers patients a safer, more manageable option—one that doesn’t involve the trauma of open-heart surgery or the helpless wait for things to get worse. It’s a chance to breathe easier, move freely, and hold on to the everyday moments that make life worth living.

Read also- Beewise: Saving Bees with AI, Robots, and a Mission to Protect the Planet

The Funding Fuel

Restore Medical recently secured a $23 million Series B funding round, led by Pitango HealthTech, Israel’s largest healthcare-focused venture capital firm, along with an unnamed global healthcare partner.

 The round also saw participation from the European Innovation Council (EIC) Fund and long-time backers Peregrine Ventures, which originally incubated the startup.

The fresh capital will be used to complete the company’s ongoing clinical studies in Europe, where initial results have shown encouraging safety and performance data.

Additionally, the funds will support the launch of a clinical trial in the United States, further accelerated by the FDA’s Breakthrough Device Designation granted in 2024—an exclusive regulatory pathway designed for technologies that address serious conditions with limited existing treatment options.

Read also- The Story of Emindset Law & Oriol Giró Canturri, How Empowering Startups and Tech with Smart Legal Solutions?

Hope, Rewired: A Way Forward for People Living with Heart Failure

The company was initially launched through Peregrine Ventures’ Incentive Incubator.

Together, Stephen Bellomo, Dr. Elchanan Bruckheimer, and Gilad Marom are now working toward developing safer, scalable solutions to address heart failure—a condition that continues to hospitalize millions worldwide, often when it’s already too late for effective intervention.

Most current device-based treatments for heart failure rely on defibrillators or mechanical heart pumps, which are invasive and typically reserved for the most critical cases.

Restore Medical’s catheter-based implant isn’t just another line on a clinical chart—it’s a lifeline, built for people who are tired of hearing “there’s nothing more we can do.” It’s minimally invasive, reversible, and designed to step in before things spiral.

For the millions living with heart failure, it’s not about high-tech jargon—it’s about getting their breath back after a flight of stairs, sleeping through the night without discomfort, or simply walking without fear. This isn’t just a device—it’s a second chance, engineered with heart.

Early clinical results are promising, showing signs that it can help reshape the heart, improve blood flow, and restore energy to patients’ everyday lives.

It’s not just about extending life—it’s about improving how people live it. If successful, this innovation could gently shift the global approach to heart failure—from managing decline to enabling recovery.

Read also- Leading with Soul: Ignacio Bonasa’s Journey from Corporate Power to Purpose-Driven Impact With Liderarte

Scaling the Vision

Restore Medical is entering a pivotal chapter—gearing up to expand regulatory approvals, ramp up manufacturing, and bring its breakthrough device to more patients worldwide.

 Backed by leading investors and bolstered by early clinical success, the startup isn’t just chasing milestones—it’s laying the foundation to redefine what heart failure treatment can look like.

 Quietly but confidently, Restore is positioning itself to become a name the world will associate with a smarter, gentler future in heart care.

In a world full of bold health-tech claims, Restore Medical is quietly building a device that could rewrite the rules of heart failure treatment. One patient at a time.

Read also- Two Visionaries Turned a Simple Idea into a Global Water-Saving Innovation: The Story Behind Kumulus Water

- Advertisement -
RELATED ARTICLES
- Advertisment -

Most Popular